Guidance of Ultrasound in Intensive Care to Direct Euvolemia
GUIDE
1 other identifier
interventional
415
1 country
1
Brief Summary
The purpose of this study is to assess the effectiveness of routine ultrasound assessments of volume status and fluid responsiveness for goal-directed therapy (GDT)-based fluid resuscitation in reducing acute kidney injury (AKI) incidence and duration in trauma patients in a teaching institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2019
CompletedFirst Posted
Study publicly available on registry
May 6, 2019
CompletedStudy Start
First participant enrolled
September 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2020
CompletedResults Posted
Study results publicly available
April 26, 2024
CompletedApril 26, 2024
March 1, 2024
10 months
May 2, 2019
June 30, 2022
March 29, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Number of Acute Kidney Injury (AKI)-Free Days
AKI will be defined by the Kidney Disease Improving Global Outcomes (KDIGO) criteria, and all stages will be considered AKI: Stage 1 - Serum Creatinine 1.5-1.9 times baseline or ≥0.3 mg/dL increase Stage 2 - Serum Creatinine 2-2.9 times baseline Stage 3 - Serum Creatinine 3 times baseline or Increase in serum creatinine to ≥4 mg/dL or Initiation of renal replacement therapy
within 7 days of injury
Number of Participants Who Receive 3 or More Ultrasound Volume Assessments
within 24 hours of ICU admission
Secondary Outcomes (14)
Number of Participants With Acute Kidney Injury (AKI)
within the first 7 days of ICU admission
Stage of Acute Kidney Injury (AKI)
within the first 7 days of ICU admission
Number of Participants With Need for Renal Replacement Therapy
within the first 30 days of ICU admission
Quantity of Fluids Administered
24 hours
Quantity of Fluids Administered
48 hours
- +9 more secondary outcomes
Study Arms (2)
Serial ultrasound assessments for GDT, then Usual Care
ACTIVE COMPARATORUsual care, then Serial ultrasound assessments for GDT
ACTIVE COMPARATORInterventions
routine ultrasound assessments of volume status and fluid responsiveness for goal-directed therapy (GDT)-based fluid resuscitation
Close hemodynamic cardiac monitoring and volume responsiveness assessment on an unscheduled basis to aid physicians in resuscitation feedback
Eligibility Criteria
You may qualify if:
- Injured patients that are admitted to the trauma ICU
You may not qualify if:
- Incarceration
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gabrielle Hatton, MD
- Organization
- The University of Texas Health Science Center at Houston
Study Officials
- PRINCIPAL INVESTIGATOR
Gabrielle Hatton, MD
The University of Texas Health Science Center, Houston
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellow
Study Record Dates
First Submitted
May 2, 2019
First Posted
May 6, 2019
Study Start
September 6, 2019
Primary Completion
June 27, 2020
Study Completion
July 20, 2020
Last Updated
April 26, 2024
Results First Posted
April 26, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share